Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Clayton Smith, MD
OncoVerity, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- University of Toronto
Toronto, Ontario, Canada
- Mcgill University Health Centre
Montreal, Quebec, Canada
- Universitaetsklinik Hamburg-Eppendorf
Hamburg, Germany
- Universitaetsklinikum Leipzig
Leipzig, Germany
- Klinikum Der Universitaet Muenchen
München, Germany
- Szpital Uniwersytecki W Krakowie
Krakow, Poland
- Wojewodzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im. M. Kopernika W Lodzi
Lodz, Poland
- Instytut Hematologii I Transfuzjologii
Warsaw, Poland
- Inselspital, Universitätsspital Bern
Bern, Switzerland
- Kantonsspital St.Gallen
Sankt Gallen, Switzerland
- City of Hope
Duarte, California, United States
- Norton Cancer Institute
Louisville, Kentucky, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Weill Cornell Medicine
New York, New York, United States
- University of Rochester
Rochester, New York, United States
- University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- University of Vermont
Burlington, Vermont, United States
- Wisconsin Medical Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Dec 2019
- Primary completion
- 15 May 2027
- Completion
- 15 May 2027
- Last update posted
- 12 May 2026
- Registered enrollment
- 61
- Registry id
- NCT04150887
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.